- Home
- DNTH vs EFSC Comparison
DNTH vs EFSC Comparison
Compare DNTH & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | EFSC |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | DNTH | EFSC |
|---|---|---|
| Price | $51.68 | $58.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $70.22 | $66.00 |
| AVG Volume (30 Days) | ★ 931.1K | 166.6K |
| Earning Date | 03-10-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | N/A | ★ 9.94 |
| EPS | N/A | ★ 5.31 |
| Revenue | $3,078,000.00 | ★ $673,715,000.00 |
| Revenue This Year | N/A | $13.88 |
| Revenue Next Year | N/A | $1.76 |
| P/E Ratio | ★ N/A | $11.06 |
| Revenue Growth | N/A | ★ 10.93 |
| 52 Week Low | $13.37 | $45.22 |
| 52 Week High | $57.50 | $62.60 |
Technical Indicators
Market Signals| Indicator | DNTH | EFSC |
|---|---|---|
| Relative Strength Index (RSI) | 64.09 | 60.03 |
| Support Level | $48.86 | $55.38 |
| Resistance Level | $57.50 | $57.30 |
| Average True Range (ATR) | 3.13 | 1.76 |
| MACD | 0.51 | 0.26 |
| Stochastic Oscillator | 61.47 | 76.24 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.